Although RON overexpression is established for various cancers [3], a query of the cBioPortal platform [40,41,42] revealed that overexpression due to genomic amplification is generally rare and was it not observed in two large-scale datasets of 219 Ewing sarcomas and cell lines accessible through the platform [43,44]. Here, MST1R is linked to cancer.